Latest by Terri Wilder, M.S.W.
What if an electronic medical record-based algorithm could make it easier and quicker to place individuals living with hepatitis C in the care cascade? That's exactly what one study is looking into, as it aims to help identify and get individuals wit...
One study set out to evaluate the role that the microbiome plays in HIV-associated neurocognitive disorders. Terri Wilder, M.S.W., spoke with study author Josue Perez-Santiago, Ph.D., at CROI 2017.
One factor that could help determine whether a person achieves an undetectable viral load is their health literacy, which is the measure of personal engagement and ability to seek medical care.
For one pharmacy in Seattle, the pharmacist plays multiple roles, doing everything from the HIV testing, to the patient education, to the prescribing of PrEP.
On behalf of TheBodyPRO.com, Terri Wilder, M.S.W., spoke with Elske Hoornenborg, M.D., who presented a case study of HIV transmission despite good adherence to pre-exposure prophylaxis (PrEP) and no drug resistance, at CROI 2017.
We asked some of the leading minds in HIV to identify barriers people have when trying to obtain pre-exposure prophylaxis (PrEP) and how to overcome them.
A person living with HIV can transmit the virus during the first six months of starting treatment. Researchers suggest extra prevention strategies for mixed-status couples during this period before viral suppression is achieved.
With the advent of short, safe treatment that can cure hepatitis C, is there still a need to identify and treat hepatitis C early?
Smoking marijuana was associated with less HIV testing, but didn't affect a patient's journey toward viral suppression, according to a study presented at CROI 2015.
As someone who "moves from theory to action fairly quickly," Daskalakis pledges to align resources with data, toward the goal of controlling HIV/AIDS without regard to a treatment or prevention silo.